Home
T. Rowe Price Investment Management reported a 10.2% stake in Denali Therapeutics DNLI · 16,178,963 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 10.2%
- Last report
- 5.4% · filed 26/05/15
- Shares held
- 16,178,963 sh
- Class
- COMMON STOCK
- Event date
- 26/06/30
- Filed
- 26/07/08
10.2% stake · +4.8pp from the last report
- Stake
- 10.2%
- Last report
- 5.4%
- Since last report
- +4.8pp
Denali Therapeutics trades, last 26 weeks
What else happened in Denali Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30T. Rowe Price Investment Management's other 5% stake reports
- T. Rowe Price Investment Management
5% stakeTeamshares
5% stakeTeamshares
TMS
18.3% stake
13,492,736 sh
18.3% stake
Filed 09/08
- T. Rowe Price Investment Management
5% stakeRevvity
5% stakeRevvity
RVTY
9.2% stake
10,261,343 sh
9.2% stake
Filed 09/08
- T. Rowe Price Investment Management
5% stakeBiolife Solutions
5% stakeBiolife Solutions
BLFS
7.5% stake
3,665,965 sh
7.5% stake
Filed 09/08
- T. Rowe Price Investment Management
5% stakeMiami International Holdings
5% stakeMiami International Holdings
MIAX
5.3% stake
5,032,970 sh
5.3% stake
Filed 08/14
- T. Rowe Price Investment Management
5% stakeM-tron Industries
5% stakeM-tron Industries
MPTI
5.9% stake
255,506 sh
5.9% stake
Filed 08/14
